METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis

Overview of attention for article published in Cancer Cell International, July 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,098 followers.

METTL7B is a novel prognostic biomarker of lower-grade glioma. #LGG https://t.co/NwP9NCLVib

New article: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis https://t.co/gPf1AHO431 #kidneycancer #oncology https://t.co/a0TdOXp9Bo

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.